BridgeBio Pharma seeks a Skeletal Dysplasia Account Manager to drive the launch of Infigratinib in a remote USA role with Southwest coverage. You will bring deep clinical knowledge, urgency, and a passion for partnering with providers and families to advance care for achondroplasia.
You will collaborate with Field Medical Directors, Field Reimbursement, and cross-functional partners to optimize outcomes for patients and families, while ensuring compliant and ethical engagement across territories.
#J-18808-Ljbffr